IL300816A - Preparations and methods for neurological diseases - Google Patents

Preparations and methods for neurological diseases

Info

Publication number
IL300816A
IL300816A IL300816A IL30081623A IL300816A IL 300816 A IL300816 A IL 300816A IL 300816 A IL300816 A IL 300816A IL 30081623 A IL30081623 A IL 30081623A IL 300816 A IL300816 A IL 300816A
Authority
IL
Israel
Prior art keywords
receptor
engineered
neuron
ligand
engineered receptor
Prior art date
Application number
IL300816A
Other languages
English (en)
Hebrew (he)
Inventor
Anthony Lau Jr
Orion P Keifer Jr
Stefanie Makinson
Alexander Naka
Original Assignee
Trames Bio Inc
Anthony Lau Jr
Orion P Keifer Jr
Stefanie Makinson
Alexander Naka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trames Bio Inc, Anthony Lau Jr, Orion P Keifer Jr, Stefanie Makinson, Alexander Naka filed Critical Trames Bio Inc
Publication of IL300816A publication Critical patent/IL300816A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL300816A 2020-08-21 2021-08-20 Preparations and methods for neurological diseases IL300816A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063068890P 2020-08-21 2020-08-21
PCT/US2021/046915 WO2022040535A2 (en) 2020-08-21 2021-08-20 Compositions and methods for neurological diseases

Publications (1)

Publication Number Publication Date
IL300816A true IL300816A (en) 2023-04-01

Family

ID=80350587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL300816A IL300816A (en) 2020-08-21 2021-08-20 Preparations and methods for neurological diseases

Country Status (11)

Country Link
US (1) US20240317834A1 (cg-RX-API-DMAC7.html)
EP (1) EP4200020A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023538130A (cg-RX-API-DMAC7.html)
KR (1) KR20230061409A (cg-RX-API-DMAC7.html)
CN (1) CN116802201A (cg-RX-API-DMAC7.html)
AU (1) AU2021329529A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023003167A2 (cg-RX-API-DMAC7.html)
CA (1) CA3192604A1 (cg-RX-API-DMAC7.html)
IL (1) IL300816A (cg-RX-API-DMAC7.html)
MX (1) MX2023002161A (cg-RX-API-DMAC7.html)
WO (1) WO2022040535A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117487904B (zh) * 2023-12-28 2024-05-31 湖南家辉生物技术有限公司 Gabrb3基因突变体、突变体蛋白、试剂、试剂盒及应用
CN119331917B (zh) * 2024-10-28 2025-10-17 北京爱思益普生物科技股份有限公司 能够表达GlyR α1/β型GlyR的细胞株及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL311984A (en) * 2016-07-07 2024-06-01 Hughes Howard Med Inst Modified ligand-gated ion channels and methods of use
IL274702B2 (en) * 2017-11-27 2026-04-01 Coda Biotherapeutics Inc Compounds and methods for neurological diseases
JP7781052B2 (ja) * 2019-08-21 2025-12-05 トレイムス バイオ, インコーポレイテッド 神経学的疾患のための組成物および方法

Also Published As

Publication number Publication date
US20240317834A1 (en) 2024-09-26
BR112023003167A2 (pt) 2023-05-02
JP2026082870A (ja) 2026-05-19
WO2022040535A2 (en) 2022-02-24
WO2022040535A3 (en) 2022-03-31
EP4200020A4 (en) 2024-11-20
AU2021329529A1 (en) 2023-04-27
EP4200020A2 (en) 2023-06-28
JP2023538130A (ja) 2023-09-06
CA3192604A1 (en) 2022-02-24
AU2021329529A9 (en) 2025-03-13
KR20230061409A (ko) 2023-05-08
CN116802201A (zh) 2023-09-22
MX2023002161A (es) 2023-05-18

Similar Documents

Publication Publication Date Title
US10538571B2 (en) Compositions and methods for neurological diseases
US20220348635A1 (en) Compositions and methods for neurological diseases
JP2026082870A (ja) 神経疾患のための組成物および方法
US20250152742A1 (en) Compositions and methods for neurological diseases
US20250163130A1 (en) Ligand gated ion channels and methods of use
BR122025015501A2 (pt) Receptor modificado, polinucleotídeo, vetor, uso dos mesmos, bem como método para expressão de um receptor modificado em um neurônio